肺癌幸存者说，医疗保险决定覆盖肺癌筛查将挽救生命

坦帕，佛罗里达州戴维将他12岁的时候开始吸烟。当他62岁的时候，他决定放弃。迪瓦恩使用Chantix的戒烟药物，用于对抗尼古丁成瘾。几个月后，当他觉得没有比在他辞职之前，甚至怀疑的东西是错误的。

前吸烟者看到提到Moffitt癌症中心的低剂量计算机断层扫描（CT）的一篇文章的肺癌筛查和决定预约。

“这一经历并没有得到一个X射线的不同。这是短暂的，无痛的。当我发现我有3肺癌的阶段，我不难过，我只是想到了所有的时间我曾试图戒烟，没有，谢天谢地，我可以开始处理我现在无癌，解释说：”Devine。

如果你有吸烟史，莫菲特肺癌筛查可以挽救你的生命。今天，医疗保险和医疗补助服务中心发布了一份最后决定备忘录，将要求医疗保险覆盖低剂量计算机断层扫描（计算机断层扫描）肺癌筛查为55岁和77岁，有吸烟史的30包年（一包一包30年或2包一天15年），并有一个书面命令从医生或合格的医生。

早期发现肿瘤的患者预后较好。现在我们有一个筛选试验，可以拯救生命，将接触到那些在高风险患肺癌，”史葛J.安东尼亚，医学博士，哲学博士，Moffitt的胸部肿瘤学系主任。“在莫菲特，我们全面评估每个CT筛查肺癌筛查方案和开发个性化的治疗计划的需要。”

M是一个综合的肺癌筛查程序， which includes a team of oncologists from a variety of specialties. As a result， Moffitt has been named a Screening Center of Excellence by the Lung Cancer Alliance. The designation lists Moffitt as one of 250 centers across the country that have agreed to follow specific protocols and core best practices to ensure the highest quality of screening and follow-up care.

“Moffitt gave me the information， support and tools I needed to beat cancer. Now， I’m an advocate for my friends who still smoke or are former smokers. The fear of the unknown was so much worse than dealing with the reality of my CT scan，” said Devine.  

The CMS decision is the last major piece in a long series of validations reaffirming the lifesaving benefits of lung cancer screening. Lung cancer screening was scientifically proved in 2010 by one of the largest randomized controlled trials in the history of the National Cancer Institute (NCI).  The NCI’s National Lung Screening Trial (NLST) confirmed that screening can reduce overall death from lung cancer， which is currently the No. 1 cancer killer in the United States.

Earlier this year， researchers at Moffitt analyzed survival rates of 635 lung cancer patients who underwent CT screens as part of the NLST study for the presence of suspicious lung nodules.  They found patients diagnosed with lung cancer who had at least one negative CT screen (i.e.， no suspicious lung nodules were found) before cancer diagnosis had poorer survival compared to patients who had at least one positive screen before their lung cancer diagnosis. The results could make it possible to identify more aggressive lung cancers found during screening and determine the best treatment for patients. Recently， a multispecialty team of researchers and clinicians from Moffitt was awarded a $1.6 million grant from the state of Florida to expand and improve the cancer center’s lung cancer screening program.

低剂量CT肺癌筛查可用于高危人群在Moffitt癌症中心和莫菲特的国际广场位置。筛选预约可以通过调用1-888-moffitt使（1-888-663-3488）或访问moffitt.org\/lungscreening。

（注：转载时请注明复诊网）